Full Life Technologies Case Study: Navigating the Radioligand Supply Chain
Full Life Technologies Case Study: Navigating the Radioligand Supply Chain
6 October 2026 14:10 14:40
In this case presentation, Philippe Van Put will share the story of how Full Life Technologies has evolved to its current position in the radiopharmaceutical landscape, highlighting the strategic, operational, and supply chain foundations that have supported its growth. He will provide an overview of the company’s journey to date, including the development of its radioligand treatment platform and current clinical trial activity.
A central focus of the presentation will be the patient journey and the critical role the supply chain plays in ensuring timely access to treatment. Philippe will explore the practical challenges and risks that arise across the end-to-end pathway, with particular emphasis on the transportation element of the supply chain, where with every handoff, timing, coordination, and execution are especially critical.
Drawing on real-world examples from Full life, he will illustrate how risk can be introduced at every handoff point, from manufacturing and release through to final delivery, and how those risks can directly affect patient access. The presentation will also consider what is needed across the ecosystem from all stakeholders — including logistics capability, planning discipline, operational coordination, and partner readiness — to overcome and address those barriers and to support the continued evolution of radioligand therapy delivery.
Overall, the session will offer a practical perspective on what it takes to ensure these highly time-sensitive treatments can reliably reach the patients who need them.
Speakers

Philippe van Put
General Manager Europe, Full Life Technologies

